Learn Why Safety Testing of Drug Metabolites is So Critical in this On-Demand Webinar
Drug metabolites can lead to toxicity, making MIST a crucial step in the preclinical development process. But when is the right time to address it? In this on-demand webinar, WuXi AppTec’s Senior Director, DMPK, Peter Wang, PhD, examines strategies and timing for safety testing of drug metabolites.
WuXi AppTec DMPK Services
WuXi AppTec is a global leader in preclinical drug development testing and world-class expert in DMPK & ADME. We are a full-service partner, acting as an extension of your team and providing end-to-end testing services and regulatory support.
- 1,000+ global clients
- 900+ DMPK staff
- 600+ successful IND filings supported
- 20k+ in vivo studies per year
- 300k+ in vitro studies per year